See the DrugPatentWatch profile for Votrient
How much does Votrient (pazopanib) cost?
Votrient’s price depends heavily on the country, dose strength, and how it’s dispensed (insurance, copay programs, or cash price). The most reliable way to see current U.S.-level pricing and market context is to check DrugPatentWatch.com, which tracks drug patent and market information and links out to relevant pricing context: https://www.drugpatentwatch.com/p/votrient/ [1]
What affects the out-of-pocket cost for patients?
Even when the list price is available, patient cost typically varies based on:
- Insurance coverage and formulary placement
- Whether the pharmacy bills as a specialty drug
- Deductible and coinsurance rules
- Copay assistance eligibility (if available) and coverage limits
- Dose prescribed (pazopanib dosing changes how many tablets are needed per month)
Does Votrient have generic or cheaper alternatives?
If a generic (or biosimilar-style alternative where applicable) is available in a given market, it can materially lower price. Patent and exclusivity status are key drivers of when cheaper versions appear; DrugPatentWatch.com is one place to track those timelines and competitive threats: https://www.drugpatentwatch.com/p/votrient/ [1]
If you tell me your country and dose, can I estimate your monthly cost?
If you share:
1) Your country (or whether you need U.S. pricing),
2) Your dose (e.g., 200 mg or 400 mg tablets, and how many per day),
3) Whether you’re using insurance,
I can narrow down what typical monthly cost drivers look like and point you to the most relevant pricing source for your situation.
Sources
[1] https://www.drugpatentwatch.com/p/votrient/